ABOS (Acumen Pharmaceuticals) OCF Yield %: -62.72 (As of Jun. 24, 2026)


ABOS Acumen Pharmaceuticals Inc ABOS
34 GF Score
Price $2.31
! 3 Warning Signs
View Full Analysis

What is Acumen Pharmaceuticals OCF Yield %?

Acumen Pharmaceuticals ABOS -3.72% 34 OCF Yield % is -62.72 as of Jun. 24, 2026. GuruFocus rates ABOS with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, Acumen Pharmaceuticals ranks worse than 85.83% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Acumen Pharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-105.55 Mil, and Market Cap is $166.85 Mil. Therefore, Acumen Pharmaceuticals's OCF Yield % for today is -62.72%.

The historical rank and industry rank for Acumen Pharmaceuticals's OCF Yield % or its related term are showing as below:

ABOS' s OCF Yield % Range Over the Past 10 Years
Min: -63.67   Med: -6.08   Max: -1.07
Current: -62.72

During the past 7 years, the highest OCF Yield % of Acumen Pharmaceuticals was -1.07%. The lowest was -63.67%. And the median was -6.08%.

ABOS's OCF Yield % is ranked worse than
85.83% of 1418 companies
in the Biotechnology industry
Industry Median: -8.55 vs ABOS: -62.72

Acumen Pharmaceuticals's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Acumen Pharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Acumen Pharmaceuticals OCF Yield % Related Terms

Acumen Pharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Acumen Pharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acumen Pharmaceuticals OCF Yield % Chart

Acumen Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -6.56 -15.87 -19.37 -83.41 -90.40

Acumen Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -204.84 -181.21 -117.74 -59.76 -56.62

ABOS vs QTTB, TNYA, MDWD: OCF Yield % Comparison

For the Biotechnology subindustry, Acumen Pharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acumen Pharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acumen Pharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Acumen Pharmaceuticals's OCF Yield % falls into.


ABOS
34GF Score
Acumen Pharmaceuticals Inc ABOS
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acumen Pharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Acumen Pharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-115.538 / 127.81325
=-90.40%

Acumen Pharmaceuticals's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-24.128 * 4 / 170.45808
=-56.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -62.72 mean?
Acumen Pharmaceuticals (ABOS) has a OCF Yield % of -62.72 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Acumen Pharmaceuticals and its competitors. According to the industry distribution chart, Acumen Pharmaceuticals ranks #1217 out of 1418 companies in the Biotechnology industry, placing it in the top 85.8%.
Is Acumen Pharmaceuticals' OCF Yield % too high?
Acumen Pharmaceuticals' current OCF Yield % is -62.72. Based on the distribution chart, Acumen Pharmaceuticals ranks #1217 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Acumen Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Acumen Pharmaceuticals' OCF Yield % compare to QTTB and TNYA?
According to the Biotechnology industry distribution chart, Acumen Pharmaceuticals ranks #1217 out of 1418 companies for OCF Yield %. This places Acumen Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Acumen Pharmaceuticals and its competitors. Acumen Pharmaceuticals's current OCF Yield % is -62.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acumen Pharmaceuticals stock overvalued right now?
Acumen Pharmaceuticals (ABOS) has a current OCF Yield % of -62.72. The current OCF Yield % is -62.72. Acumen Pharmaceuticals' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Acumen Pharmaceuticals (ABOS), the current OCF Yield % is -62.72 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acumen Pharmaceuticals Business Description

Address 1210-1220 Washington Street, Suite 210, Newton, MA, USA, 02465
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
34GF Score

Get the complete analysis for ABOS

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.31
Price